Multimodal therapy approaches that combine interventions aimed at different aspects of disease are emerging as potential?and perhaps essential?ways to enhance clinical outcomes for patients with psychiatric and neurological disorders. In…

Globalization is rapidly changing lives and industries around the world. Drug development, authorization, and regulatory supervision have become international endeavors, with most medicines becoming global commodities. Drug companies utilize global…

Chronic sleep disorders affect one in five Americans, and sleep deprivation costs significant U.S. GDP loss annually. Despite the indisputable biological importance of sleep, much remains unknown about underlying mechanisms.

…

Governments, philanthropic organizations, and private industry fund human health and medical research. Various funding sources might bias research so that the results are more favorable to their agents. Funders may…

As the United States continues to adapt to a more digital, mobile, and interconnected world, health care and public health professionals have sought to better prepare for and respond to…

Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: a workshop, October 11-12, 2017, Keck Center, Room 100, 500 Fifth Street, NW, Washington, DC –Page 77.

Over the past several decades, supply chain disruptions have repeatedly plagued the U.S. health care system, costing health care systems millions of dollars per year, threatening the clinical research enterprise…

The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing…